INS and Cushing syndrome: The insulin-producing pancreatic beta-cell may be extra susceptible to GC excess, since both iatrogenic Cushing syndrome and GC-induced diabetes in animal models are associated with loss of glucose-stimulated insulin secretion (GSIS), and GC immunosuppressive treatment adversely affects islet transplantation outcome [2].